NCT01632436 2023-10-02
Hepatic
CTI BioPharma
Phase 1 Withdrawn
Clinical Trials
3 trialsNCT00577161 2020-10-05
Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
CTI BioPharma
Phase 3 Withdrawn
NCT02800889 2020-01-29
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
CTI BioPharma
Phase 1 Withdrawn